242 related articles for article (PubMed ID: 30187949)
1. Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-κB signaling.
Han X; Tang J; Chen T; Ren G
J Cell Biochem; 2019 Jan; 120(1):917-927. PubMed ID: 30187949
[TBL] [Abstract][Full Text] [Related]
2. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.
Yang Y; Song S; Li S; Kang J; Li Y; Zhao N; Ye D; Qin F; Du Y; Sun J; Yu T; Wu H
Cell Death Dis; 2024 Apr; 15(4):289. PubMed ID: 38653973
[TBL] [Abstract][Full Text] [Related]
3. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
4. Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway.
Wang TP; Hsu SH; Feng HC; Huang RF
Carcinogenesis; 2012 Jun; 33(6):1158-68. PubMed ID: 22461522
[TBL] [Abstract][Full Text] [Related]
5. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
6. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
[TBL] [Abstract][Full Text] [Related]
7. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
8. Silence of TPPP3 suppresses cell proliferation, invasion and migration via inactivating NF-κB/COX2 signal pathway in breast cancer cell.
Ren Q; Hou Y; Li X; Fan X
Cell Biochem Funct; 2020 Aug; 38(6):773-781. PubMed ID: 32515139
[TBL] [Abstract][Full Text] [Related]
9. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
12. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Apoptosis and Epithelial-Mesenchymal Transition E-cadherin/TGF-β/Snail/TWIST Pathways by a New Ciprofloxacin Chalcone in Breast Cancer Cells.
Alaaeldin R; Abuo-Rahma GEA; Zhao QL; Fathy M
Anticancer Res; 2021 May; 41(5):2383-2395. PubMed ID: 33952463
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
Hu XL; Wang J; He W; Zhao P; Wu WQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3074-3084. PubMed ID: 29863253
[TBL] [Abstract][Full Text] [Related]
15. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
Zeng Q; Li S; Zhou Y; Ou W; Cai X; Zhang L; Huang W; Huang L; Wang Q
Cytokine; 2014 Jan; 65(1):24-32. PubMed ID: 24140068
[TBL] [Abstract][Full Text] [Related]
18. MiR-182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF-κB signaling pathway in endometriosis.
Wu M; Zhang Y
Mol Cell Biochem; 2021 Mar; 476(3):1575-1588. PubMed ID: 33400022
[TBL] [Abstract][Full Text] [Related]
19. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
Feng ZM; Guo SM
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
[TBL] [Abstract][Full Text] [Related]
20. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
